Instead, clinicians should acknowledge this risk and consider individualized risk-benefit strategies when prescribing GLP-1 RAs, particularly for patients with pre-existing ocular manifestations and must inform patients regarding possible ocular hazards while advocating for regular retinal examinations and assessments of visual acuity
But the risk of low blood sugar levels often only goes up if youre also taking another drug known to lower blood sugar at the same time, such as sulfonylureas or insulin
However, insurance coverage for Victoza and Saxenda can vary
anti-Mfn2, SANTA #sc-100560 1:1000
Our experienced legal team can: Verify your eligibility to file a lawsuit during a free, no-obligation case review
In October 2024, tirzepatide was removed from the FDA drug shortage list, improving availability for patients